浙江京新药业回购进展：已回购4727.13万股，金额达6.09亿元

Group 1 - The company Zhejiang Jingxin Pharmaceutical Co., Ltd. has made significant progress in its share repurchase plan, with a total of 47.27 million shares repurchased as of August 31, 2025, representing 5.49% of the current total share capital [3] - The initial repurchase plan set a total amount between 200 million yuan and 400 million yuan, with a maximum repurchase price of 14.80 yuan per share, later adjusted to a range of 350 million yuan to 700 million yuan and a price cap of 14.47 yuan per share [2] - The total amount spent on repurchased shares reached approximately 608.72 million yuan, with the highest transaction price at 14.41 yuan per share and the lowest at 11.86 yuan per share [3] Group 2 - The company plans to continue its share repurchase based on market conditions and will fulfill its information disclosure obligations [3] - The repurchase is intended for employee stock ownership plans or equity incentives, aligning with the company's strategic goals [2]